Restoration of NK Cell Cytotoxic Function With Elotuzumab and Daratumumab Promotes Elimination of Circulating Plasma Cells in Patients With SLE
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Restoration of NK Cell Cytotoxic Function With Elotuzumab and Daratumumab Promotes Elimination of Circulating Plasma Cells in Patients With SLE
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-03-22
DOI
10.3389/fimmu.2021.645478
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The CD38/NAD/SIRTUIN1/EZH2 Axis Mitigates Cytotoxic CD8 T Cell Function and Identifies Patients with SLE Prone to Infections
- (2020) Eri Katsuyama et al. Cell Reports
- Glucocorticoids and the cytokines IL-12, IL-15 and IL-18 present in the tumor microenvironment induce PD-1 expression on human Natural Killer cells
- (2020) Linda Quatrini et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Changes of frequency and expression level of CD161 in CD8 + T cells and natural killer T cells in peripheral blood of patients with systemic lupus erythematosus
- (2020) Yumi Park et al. MICROBIOLOGY AND IMMUNOLOGY
- Autoimmunity and organ damage in systemic lupus erythematosus
- (2020) George C. Tsokos NATURE IMMUNOLOGY
- Targeting CD38 with Daratumumab in Refractory Systemic Lupus Erythematosus
- (2020) Lennard Ostendorf et al. NEW ENGLAND JOURNAL OF MEDICINE
- CyTOFmerge: Integrating mass cytometry data across multiple panels
- (2019) Tamim Abdelaal et al. BIOINFORMATICS
- New therapies for systemic lupus erythematosus — past imperfect, future tense
- (2019) Grainne Murphy et al. Nature Reviews Rheumatology
- Autoantibodies to Killer Cell Immunoglobulin-Like Receptors in Patients With Systemic Lupus Erythematosus Induce Natural Killer Cell Hyporesponsiveness
- (2019) Filip Segerberg et al. Frontiers in Immunology
- Downregulation of CD3ζ in NK Cells from Systemic Lupus Erythematosus Patients Confers a Proinflammatory Phenotype
- (2018) Abel Suárez-Fueyo et al. JOURNAL OF IMMUNOLOGY
- Elotuzumab: A Review in Relapsed and/or Refractory Multiple Myeloma
- (2018) Yvette N. Lamb DRUGS
- SLAMF1 engagement inhibits T cell-B cell interaction and diminishes IL-6 production and plasmablast differentiation in systemic lupus erythematosus
- (2018) Maria P. Karampetsou et al. Arthritis & Rheumatology
- Signaling lymphocyte activation molecule family in systemic lupus erythematosus
- (2018) Denis Comte et al. CLINICAL IMMUNOLOGY
- 2B4 (CD244, SLAMF4) and CS1 (CD319, SLAMF7) in systemic lupus erythematosus and cancer
- (2018) Joseph D. Malaer et al. CLINICAL IMMUNOLOGY
- SLAM family receptors in natural killer cells – Mediators of adhesion, activation and inhibition via cis and trans interactions
- (2018) Maren Claus et al. CLINICAL IMMUNOLOGY
- Signaling Lymphocytic Activation Molecule Family Member 7 Engagement Restores Defective Effector CD8+ T Cell Function in Systemic Lupus Erythematosus
- (2017) Denis Comte et al. Arthritis & Rheumatology
- Expression patterns of signaling lymphocytic activation molecule family members in peripheral blood mononuclear cell subsets in patients with systemic lupus erythematosus
- (2017) Maria P. Karampetsou et al. PLoS One
- The Self-Specific Activation Receptor SLAM Family Is Critical for NK Cell Education
- (2016) Shasha Chen et al. IMMUNITY
- Engagement of SLAMF3 enhances CD4+T-cell sensitivity to IL-2 and favors regulatory T-cell polarization in systemic lupus erythematosus
- (2016) Denis Comte et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- T cell signaling abnormalities contribute to aberrant immune cell function and autoimmunity
- (2015) Vaishali R. Moulton et al. JOURNAL OF CLINICAL INVESTIGATION
- Recent findings on the role of natural killer cells in the pathogenesis of systemic lupus erythematosus
- (2015) R. Spada et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Analysis of expression and function of the co-stimulatory receptor SLAMF1 in immune cells from patients with systemic lupus erythematosus (SLE)
- (2015) L Liñán-Rico et al. LUPUS
- Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma
- (2015) Sagar Lonial et al. NEW ENGLAND JOURNAL OF MEDICINE
- Selective Loss of Signaling Lymphocytic Activation Molecule Family Member 4-Positive CD8+ T Cells Contributes to the Decreased Cytotoxic Cell Activity in Systemic Lupus Erythematosus
- (2015) Katalin Kis-Toth et al. Arthritis & Rheumatology
- The Swiss Systemic lupus erythematosus Cohort Study (SSCS) – cross-sectional analysis of clinical characteristics and treatments across different medical disciplines in Switzerland
- (2015) C Ribi et al. SWISS MEDICAL WEEKLY
- Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus
- (2012) Michelle Petri et al. ARTHRITIS AND RHEUMATISM
- The role of Tumor Necrosis Factor-alpha (TNF-α) in the pathogenesis of systemic lupus erythematosus
- (2011) Mariana Postal et al. CYTOKINE
- Systemic Lupus Erythematosus
- (2011) George C. Tsokos NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More